Company News
Orphan Biovitrum CEO Exit, Stock Falls 5%
Shares of Swedish Orphan Biovitrum AB dropped 5% on Monday after announcing CEO Guido Oelkers will step down in early 2027.
Oelkers will remain in the CEO role until the end of January 2027, providing